Molecular Attraction AB

Molecular Attraction is a biotechnology startup founded in 2017 and based in Sweden. The company specializes in developing groundbreaking vector-diseases control and eradication strategies through its Molecular Attraction technology. This innovative approach involves identifying biological compounds that can alter the behavior of vector organisms such as mosquitoes, flies, and rodents. The Molecular Attraction compounds encompass volatile attractants, phagostimulants, and pheromones. The company's expertise lies in biochemical compound identification, insect behavior, as well as parasitic infections biochemistry and immunology. Molecular Attraction has secured a recent Venture Round investment on 22 March 2023 from EIC Accelerator, further validating its potential to revolutionize vector control. This latest injection of funding is set to propel Molecular Attraction's pioneering efforts in the biotechnology sector.